<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775871/" ref="ordinalpos=4309&amp;ncbi_uid=6451353&amp;link_uid=PMC3775871" image-link="/pmc/articles/PMC3775871/figure/F5/" class="imagepopup">Figure 5. The regulation of SOX9 by NF-κB <span class="highlight" style="background-color:">signaling</span> is dependent on DNA methylation.  From: Epigenetic Regulation of SOX9 by the NF-?B <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> in Pancreatic Cancer Stem Cells. </a></div><br /><div class="p4l_captionBody">(A, B) The enrichment of SOX9 promoter is dramatically enhanced by treatment of DNA demethylating agents 5AZA or Zebularine using either ChIP (A) or EMSA (B) assays.(C) A proposed model for the function of NF-κB signaling and SOX9 in pancreatic cancer cells. In non-invasive cells, the SOX9 promoter is methylated and SOX9 expression is silenced. In the invasive population, or CSCs, in which SOX9 promoter is demethylated, NF-κB complex binds to SOX9 promoter and activates SOX9 expression, contributing to the invasiveness of pancreatic CSCs.</div></div>